Madrigal Pharmaceuticals Inc (MDGL)
347.45
+18.21
(+5.53%)
USD |
NASDAQ |
Nov 22, 16:00
348.00
+0.55
(+0.16%)
After-Hours: 20:00
Madrigal Pharmaceuticals Price: 347.45 for Nov. 22, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 22, 2024 | 323.72 | 351.06 | 322.73 | 347.45 | 537169.0 |
| Nov 21, 2024 | 318.42 | 329.93 | 315.15 | 329.24 | 423638.0 |
| Nov 20, 2024 | 315.75 | 323.99 | 310.84 | 317.09 | 326802.0 |
| Nov 19, 2024 | 305.00 | 320.88 | 304.35 | 314.17 | 380892.0 |
| Nov 18, 2024 | 290.25 | 308.43 | 288.80 | 303.49 | 467873.0 |
| Nov 15, 2024 | 303.29 | 303.29 | 272.72 | 288.58 | 945981.0 |
| Nov 14, 2024 | 310.94 | 315.56 | 302.54 | 302.67 | 405256.0 |
| Nov 13, 2024 | 342.58 | 342.58 | 314.02 | 315.15 | 505186.0 |
| Nov 12, 2024 | 335.57 | 341.19 | 327.41 | 339.04 | 374182.0 |
| Nov 11, 2024 | 357.42 | 357.81 | 338.03 | 339.66 | 331689.0 |
| Nov 08, 2024 | 356.71 | 357.04 | 343.00 | 350.70 | 454434.0 |
| Nov 07, 2024 | 339.38 | 368.29 | 337.50 | 354.85 | 675804.0 |
| Nov 06, 2024 | 341.59 | 345.04 | 327.69 | 338.22 | 592443.0 |
| Nov 05, 2024 | 331.00 | 337.63 | 316.66 | 337.61 | 773478.0 |
| Nov 04, 2024 | 320.00 | 337.44 | 310.02 | 331.32 | 1.041M |
| Nov 01, 2024 | 274.98 | 321.19 | 262.85 | 319.58 | 3.057M |
| Oct 31, 2024 | 245.66 | 263.54 | 238.04 | 259.34 | 1.354M |
| Oct 30, 2024 | 214.85 | 218.40 | 213.71 | 215.93 | 311898.0 |
| Oct 29, 2024 | 215.04 | 218.42 | 214.20 | 217.79 | 215544.0 |
| Oct 28, 2024 | 210.32 | 217.19 | 210.32 | 217.00 | 209211.0 |
| Oct 25, 2024 | 203.18 | 213.00 | 203.18 | 210.67 | 565768.0 |
| Oct 24, 2024 | 201.93 | 205.59 | 201.22 | 202.99 | 265073.0 |
| Oct 23, 2024 | 204.44 | 204.44 | 200.63 | 202.48 | 329038.0 |
| Oct 22, 2024 | 208.20 | 209.40 | 202.42 | 203.59 | 332917.0 |
| Oct 21, 2024 | 213.01 | 213.02 | 208.15 | 208.89 | 165177.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
55.89
Minimum
Jan 27 2022
354.85
Maximum
Nov 07 2024
148.56
Average
116.46
Median
Price Benchmarks
| Corcept Therapeutics Inc | 57.54 |
| ADMA Biologics Inc | 21.18 |
| 89bio Inc | 8.76 |
| Matinas BioPharma Holdings Inc | 0.6159 |
| Viking Therapeutics Inc | 52.59 |
Price Related Metrics
| PEG Ratio | -0.4526 |
| Price to Book Value | 9.751 |
| Earnings Yield | -7.23% |
| Market Cap | 7.578B |
| PEGY Ratio | -0.4526 |